Japanese Study Looks at Rates of Cancer Therapy–Related AML - Takeaway - MDSpire
From the Journals

Japanese Study Looks at Rates of Cancer Therapy–Related AML

A population-based study in Japan has revealed a gradual increase in the rates of therapy-related acute myeloid leukemia (AML) in recent years—especially after breast cancer treatment. 

Share

  • 1

    tAML is therapy-related acute myeloid leukemia.

  • 2

    Study reveals rising tAML incidence among cancer survivors.

  • 3

    Increased from 0.13 to 0.36 per 100,000 population from 1990 to

  • 4

    6.5% of AML cases were tAML.

  • 5

    Common primary cancers leading to tAML included blood cancer, breast cancer, and colorectal cancer.

  • 6

    Research conducted using Osaka Cancer Registry data.

  • 7

    The increase in tAML suggests changing risks for cancer survivors.

Original Source(s)

Japanese Study Looks at Rates of Cancer Therapy–Related AML

  • by The ASCO Post Staff

  • April 9, 2026

Related Content

In Celebration of a Decades-Long Journey of Discovery and Innovation

On October 1, 2025, Benjamin L. Ebert, MD, PhD, celebrated the 1-year anniversary of being named President and Chief Executive Officer (CEO) of Dana-Farber Cancer Institute in Boston. He also holds th...

How Cannabis Use May Be Accelerating Breast and Testicular Cancer Rates in AYAs

“The evidence from our study implicates cannabis as a potential etiologic factor contributing to the rising incidence of breast cancer in young females and testis cancer in older adolescent and young ...

Small Phase II Study Examines Triplet Regimen for Patients With HER2-Positive Breast Cancer and Leptomeningeal Metastasis

Results from a small phase II study suggest that a triplet regimen may improve symptoms and extend survival in some patients with breast cancer and leptomeningeal metastasis, who often face limited tr...